Ledifos 90mg-400mg Tablet

Ledifos 90mg-400mg Tablet Specification

Indication
Treatment of chronic Hepatitis C Virus (HCV) genotype 1, 4, 5, or 6 infection

Pacakaging (Quantity Per Box)
28 tablets / box

Life Span
24 months from date of manufacture

Brand Name
Ledifos

Dosage Form
Oral tablet

Salt Composition
Ledipasvir (90mg), Sofosbuvir (400mg)

Origin of Medicine
India

Packaging Type
Bottle

Drug Type
General Medicines

Ingredients
Ledipasvir 90mg and Sofosbuvir 400mg

Physical Form
Tablets

Function
Antiviral treatment

Recommended For
Chronic Hepatitis C infection

Dosage
As Suggested

Dosage Guidelines
Take at the same time each day; do not crush or split the tablet

Suitable For
Adults

Quantity
28 tablets per bottle

Storage Instructions
Cool Place

International Brand Equivalent
Harvoni

Drug Interactions
May interact with amiodarone, antacids, rifampin, St. John's Wort

Prescription Required
Yes

Administration Route
Oral

Color
Yellow, film coated

Patient Population
Not for use in children under 18

Usage Restrictions
Not recommended in severe renal impairment without medical supervision

Marketed By
Hetero Drugs Ltd.

Shape
Oval

Warning
Consult a healthcare professional before starting treatment; not for use during pregnancy unless prescribed

Side Effects
Common: fatigue, headache, nausea

Shelf Life
2 years

Therapeutic Class
Antiviral agents

Ledifos 90mg-400mg Tablet Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Ledifos 90mg-400mg Tablet

Last Chance to capitalise on an astounding solution for managing chronic Hepatitis C with Ledifos 90mg-400mg Tablet. This brilliant, first-class antiviral treatment combines Ledipasvir and Sofosbuvir, matching international brand Harvoni's efficacy. Designed for adults, each yellow, oval, film-coated tablet delivers potent relief via oral administration. Marketed by Hetero Drugs Ltd., Ledifos offers a two-year shelf life and is available in bottles of 28. Access first-class care-strictly by prescription-helping to transform HCV management. Store in a cool place. Consult your healthcare provider before use.

Features, Patient Profile, and Usage Guidance

Ledifos 90mg-400mg Tablet features a high-quality, film-coated formulation ideal for adults requiring effective HCV genotype 1, 4, 5, or 6 therapy. Used exclusively under medical supervision, it is not recommended for children under 18 or those with severe renal impairment. The oral, once-daily administration simplifies treatment routines, while strict dosage guidelines must be followed for optimal results. Experience steady viral suppression through consistent daily intake, allowing patients to maintain their routines and lifestyle.

Certifications, Export Ventures, and Sample Policy

Ledifos 90mg-400mg Tablet, manufactured by Hetero Healthcare Ltd., holds necessary certifications tailored for global export markets. Handed over only against valid purchase orders and prescriptions, its supply ability meets both wholesale and retail demands. Genuine samples can be provided as per the exporter's sample policy, facilitating international buyers in making informed purchasing decisions. The product's reputation, backed by quality and reliability, is assuring for partners and distributors entering the Hepatitis C antiviral segment.

Specification

Form	Tablet
Manufacturer	Hetero Healhcare Ltd.
Prescription/Non prescription	Prescription
Brand	Ledifos
Treatment	Chronic Hepatitis C
Composition	Ledipasvir (90 mg) + Sofosbuvir (400 mg)
Packaging Size	28 Tablets Per Bottle
Packaging Type	Strip

FAQ's of Ledifos 90mg-400mg Tablet:

Q: How should Ledifos 90mg-400mg Tablet be administered for best results?

A: Ledifos should be taken exactly as prescribed by your healthcare provider, usually once daily at the same time each day, without crushing or splitting the tablet. Follow all dosage instructions for optimal effectiveness.

Q: What are the primary benefits of using Ledifos for chronic Hepatitis C?

A: Ledifos combines Ledipasvir and Sofosbuvir to provide a brilliant, first-class antiviral therapy, offering patients a high cure rate for hepatitis C genotypes 1, 4, 5, and 6, while simplifying the daily treatment process.

Q: When should Ledifos use be avoided?

A: Ledifos is not recommended for patients with severe renal impairment without strict medical supervision, nor is it suitable for children under 18 or for use during pregnancy unless advised by your physician.

Q: Where is Ledifos 90mg-400mg Tablet manufactured and supplied from?

A: Ledifos is manufactured by Hetero Healthcare Ltd. in India, and is available for export, wholesale, and retail-subject to valid prescriptions and purchase orders in global markets.

Q: What side effects should I watch for while taking Ledifos?

A: Common side effects include fatigue, headache, and nausea. It's important to consult your healthcare professional if you experience any unusual or serious symptoms during treatment.

Q: What precautions should be taken before starting Ledifos?

A: Always consult your healthcare provider before initiating Ledifos. Disclose any medications you take, especially amiodarone, antacids, rifampin, or St. John's Wort, due to potential drug interactions.